International Flavors & Fragrances Inc.

IFF · NYSE · USD

Analysis

Last 4 earnings calls · through Q2 FY2026

IFF has finished shrinking itself into a smaller, higher-margin company. The Food Ingredients sale is the last step, and the calls say the growth now comes from volume rather than price, so the test is whether the sales it gave up and the costs it kept leave it better off. How much of IFF's growth came from volume versus price, by division?

  • Volume, not price, is now carrying the growth.

    In both Q1 and Q2 FY2026 the growth was volume-driven, and in Q2 pricing added next to nothing. Volume carries an incremental margin of roughly 30%, so new wins lift profit more than the same sales from price increases would. How do IFF's volume growth and margins compare with its flavor peers?

  • The company shrank its way to better margins.

    Food Ingredients goes to CVC at about 10 times its earnings, and what stays behind is a smaller IFF with higher margins: Q1 FY2026 was its best margin quarter since 2022. Those three now have to grow faster than the one sold.

  • Cash was the weak spot, and management says so.

    Free cash flow fell to roughly $250 million in 2025, hit by an inventory build and a rise in capital spending; the CEO said he was 'not as proud' of how inventory was managed. That is the number the Food Ingredients sale must not undo. How much working capital will IFF's separation costs tie up next year?

Bullish
  • Portfolio focus after divestitures
    The bull case is that selling Food Ingredients leaves three businesses that grow faster and earn better margins than the company did as a whole.
  • Volume-led growth
    Growth now comes from volume and new customer wins rather than price, which management says carries strong incremental margins as sales rise.
  • Stranded costs removed
    Management plans to strip out the overhead left behind by the divestiture, which would lift segment margins without needing more sales.
Bearish
  • Commodity ingredient competition
    The bear case is that much of the external fragrance ingredient business competes on price with Asian producers and the shift to specialties keeps slipping.
  • North American health weakness
    The health business in North America has not recovered as promised, and the company now points to market conditions rather than to its own execution.
  • Middle East cost pressure
    Energy and logistics inflation tied to the Middle East is arriving before customer surcharges take effect, and Fine Fragrance demand in the region is weaker.
See the full bull & bear case
PoliticiansInstitutionsInsiders
PoliticianTransactionAmountTradedFiled
Donald Trump
Republican · Executive
Sale≥$1KJun 12Aug 22
Donald Trump
Republican · Executive
Purchase≥$1KMay 11Jul 1
Donald Trump
Republican · Executive
Purchase≥$1KMar 17May 13
Ro Khanna
Democratic · House · CA-17
Purchase≥$1KApr 13May 11
Michael T. McCaul
Republican · House · TX-10
Purchase≥$100KJan 13Feb 11

Congressional trading data provided by QuiverQuant

See all
Product segmentsGeography
FY2025 · USD

How International Flavors & Fragrances turned $10.9B of revenue into $3.9B of gross profit.

Revenue
Food Ingredients$3.3B
Taste$2.5B
Scent$2.5B▲ 1.60% YoY
Health & Biosciences$2.3B▲ 8.10% YoY
Pharma Solutions$369.0M▼ 61.60% YoY
Total revenue$10.9B
Gross profit$3.9B36.2%
See all